برازش اح. (1394). روابط سیاسی - دیپلماتیک ایران و جهان در عهد صفویه. تهران: انتشارات امیرکبیر.
پورقاسمی م. (1397). کتاب مقررات صادرات و واردات سال ۱۳۹۷. تهران: شرکت چاپ و نشر بازرگانی.
رحمانی م، عابدین‌مقانکی م‌ر. (1387). «بررسی امکان توسعه صادرات ایران با شرکای تجاری منتخب». پژوهشنامۀ بازرگانی. 12(46): 177- 145.
شهبازی ک، اسدی ف. (1393). «تأثیر افزایش نرخ ارز بر واردات دارو و تجهیزات پزشکی.
نشریة سیاست‌گذاری اقتصادی. 6(11): 35-54.
محمود‌زاده م، کریمی م، حسن‌پور ی. (1391). «تحلیل رقابتمندی ایران در صادرات دارو».
نشریة سیاست‌گذاری اقتصادی. 4(7): 55- 78.
نصابیان ش، غلامحسینی ط، جبل‌عاملی ف. (1391). «مقایسه مزیت نسبی صادرات گیاهان دارویی ایران با سایر کشورهای صادرکننده (مطالعه موردی: رازیانه, بادیان, انیسون و گشنیز)». مدل‌سازی اقتصادی. 6(4): 75-92.
ولی بیگی ح، فهیمی‌فر ج، عابدین‌زاده م‌ر. (1383). «بررسی رقابت پذیری صادراتی صنعت قطعات خودرو ایران در بازارهای صادراتی». پژوهشنامة بازرگانی. 170- 172.
Allen SRGD. (1957). Mathematical Economics. London: Macmillan & Co.
Bert T. (2008). “Parallel trade of pharmaceuticals: A review of legal, economic, and political aspects”. Value in Health. 11(5): 996–1005. doi: 10.1111/j.1524-4733.2008.00339.x.
Bojnec S, Ferto I. “Export competitiveness of dairy products on global markets: The case of the European Union countries”. Journal of Dairy Science. 97(10): 6151–6163. doi: 10.3168/jds.2013-7711.
Chadha A. (2009). “Product cycles, innovation, and exports: A study of Indian pharmaceuticals”. World Development. 37(9): 1478–1483. doi: 10.1016/j.worlddev.2009.01.002.
Chaudhry P, Dacin P. (1997). “Strategic planning in a regulated trade bloc: The pharmaceutical industry in the European Union”. European Management Journal. 15(6): 686–697. doi: 10.1016/S02632373(97)00052-2.
Emamgholipour S, Aghel L. (2019). “Determining the structure of pharmaceutical industry in Iran”.
International Journal of Pharmaceutical and Healthcare Marketing. 13(1): 101–115. doi:
https://doi.org/10.1108/IJPHM-06-2017-0030.
Garattini L, Padula A. (2018). “Competition in pharmaceuticals: more product– than price-oriented?”. The European Journal of Health Economics. 19: 1–4. doi: 10.1007/s10198-0170932-4.
Haghayegh R, Hassangholipoor T. (2017). “Iran-Russia commercial relations; A strategy for non-oil trading development”. International Relations Research. 1(27): 281-312.
Holownia-Voloskova M, Vorobiev PA, Grinin M, Davydovskaya M, Ermolaeva, T, Kokushkin K. (2018). “Drug policy in the Russian Federation”. Value in Health Regional Issues. 16: 106–111. doi: 10.1016/j.vhri.2018.09.001.
ICCIMA: Iran Chamber of Commerce, Industries, Mines and Agriculture (2017). https://iccima.ir/. (Assessed on 10/06/2017).
Karami J, Rasoulinezhad E, Shokri Sh. (2019). “Discussion on Russia-Iran bilateral trade in the modern era with emphasis on Russia’s economy”.
Journal of World Sociopolitical Studies. 3(1): 161–198. doi:
https://doi.org/10.22059/wsps.2019.272325.1079.
Koolaee E, Abedi A. (2018). “Developments of Iran-Russia relations, 1992–2016”. Studies of International Relations Journal. 10 (40): 135–164.
Miclitz W. (1988). “EC regulation of the export of dangerous pharmaceuticals to Third World countries: Some prospects”. Journal of Consumer Policy. 11: 29-53. doi: 10.1007/bf00411519.
Palumbo FB, Mullins CD, Slagle AF, Rizer J. (2007). “Policy implications of drug importation”. Clinical Therapeutics. 29(12): 2758–2767. doi: 10.1016/j.clinthera.2007.12.029.
Rasoulinezhad E. (2016). “Investigation of sanctions and oil price effects on the Iran-Russia trade by using the gravity model”.
Vestnik SPBGU. 5(2): 68–84. doi:
10.21638/11701/spbu05.2016.204.
Settanni E, Seosamh Harrington T, Srai JS. (2017). “Pharmaceutical supply chain models: A synthesis from a systems view of operations research”. Operations Research Perspectives. 4: 74–95. doi: 10.1016/j.orp.2017.05.002.
SPS Requirements for Exporting to the Russian Federation (2010), Translation of the Regulation APPROVED by the Decision of the Customs Union Commission. May 28, No 299.
Tannoury M, Attieh Z. (2017). “The influence of emerging markets on the pharmaceutical industry”.
Current Therapeutic Research. 86: 19–22. doi:
10.1016/j.curtheres.2017.04.005.
Vassilieva Y. (2010). “Agricultural Ministry Sets Procedure for Examining Russian SPS Norms”. Global Agricultural Information Network. GAIN Report Number:RS1026.
Yu R, Cai J, Leung P. (2008). “The normalized revealed comparative advantage index”. The Annals of Regional Science. 43: 267–282. doi: 10.1007/s00168-008-0213-3.
Zargarzadeh A, Minaeiyan M, Torabi A. (2008). “Prescription and nonprescription drug use in Isfahan, Iran: An observational, cross-sectional study”.
Current Therapeutic Research. 69(1): 76–87. doi:
10.1016/j.curtheres.2008.02.002.
)